NEU 1.07% $14.20 neuren pharmaceuticals limited

Ann: 2023 Results webinar, page-40

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,239 Posts.
    lightbulb Created with Sketch. 317
    he did mention to the effect of 'shareholders and financials are a very important part of the consideration when it comes to the pathways'. You can argue that it's an investor call and he had to say that but I do think that Neuren management on its own is not going to be able to carry out potentially 4 phase 3 trials at the same time while exploring other potential indications as he pointed out
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.